EXOZ
Price:
$7.1
Market Cap:
$60.20M
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entirely new molecular entities. Integral to its design, the SimplePath platform incorporates distinct modules, each housing one or more enzymes that work synergistically to facilitate specific biocatalytic transformations. The firm was established in 2014 and maintains its corporate headquarters in Monrovia, California.
Industry
Biotechnology
IPO Date
2024-11-13
Stock Exchange
NASDAQ
Ticker
EXOZ
According to eXoZymes, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.32. This represents a change of -63.69% compared to the average of 3.64 of the last 4 quarters.
The mean historical Current Ratio of eXoZymes, Inc. over the last ten years is 3.21. The current 1.32 Current Ratio has changed 4.01% with respect to the historical average. Over the past ten years (40 quarters), EXOZ's Current Ratio was at its highest in in the December 2024 quarter at 8.12. The Current Ratio was at its lowest in in the March 2023 quarter at 0.
Average
3.21
Median
2.51
Minimum
0.50
Maximum
8.12
Discovering the peaks and valleys of eXoZymes, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.52%
Maximum Annual Current Ratio = 8.12
Minimum Annual Increase = -78.31%
Minimum Annual Current Ratio = 0.50
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.51 | -69.02% |
| 2024 | 8.12 | 1.52% |
| 2023 | 0.50 | -78.31% |
| 2022 | 2.32 | -11.29% |
The current Current Ratio of eXoZymes, Inc. (EXOZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.71
5-year avg
3.21
10-year avg
3.21
eXoZymes, Inc.’s Current Ratio is greater than Estrella Immunopharma, Inc. (0.24), less than Greenwich LifeSciences, Inc. (2.01), less than Atossa Therapeutics, Inc. (4.92), less than Tiziana Life Sciences Ltd (8.79), greater than Tevogen Bio Holdings Inc. (0.29), less than Surrozen, Inc. (11.91), less than Oncolytics Biotech Inc. (1.38), less than Instil Bio, Inc. (39.87), less than Anebulo Pharmaceuticals, Inc. (16.71), less than Cognition Therapeutics, Inc. (5.92),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.24 | $45.62M | |
| 2.01 | $353.16M | |
| 4.92 | $21.18M | |
| 8.79 | $65.37M | |
| 0.29 | $43.84M | |
| 11.91 | $174.90M | |
| 1.38 | $80.59M | |
| 39.87 | $53.71M | |
| 16.71 | $19.37M | |
| 5.92 | $89.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like eXoZymes, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like eXoZymes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is eXoZymes, Inc.'s Current Ratio?
How is the Current Ratio calculated for eXoZymes, Inc. (EXOZ)?
What is the highest Current Ratio for eXoZymes, Inc. (EXOZ)?
What is the 3-year average Current Ratio for eXoZymes, Inc. (EXOZ)?
What is the 5-year average Current Ratio for eXoZymes, Inc. (EXOZ)?
How does the current Current Ratio for eXoZymes, Inc. (EXOZ) compare to its historical average?